期刊文献+

栀子苷对氧嗪酸钾盐致小鼠高尿酸血症的作用及其机制研究 被引量:35

Effect of jasminoidin on potassium oxonate-induced hyperuricemia in mice and its mechanism
原文传递
导出
摘要 目的探讨栀子苷对氧嗪酸钾盐致小鼠高尿酸血症的作用及其机制。方法连续7 d灌胃给予氧嗪酸钾盐诱导小鼠高尿酸血症,对比各组血清尿酸水平和24 h尿酸排泄量,检测肝脏黄嘌呤氧化酶(XOD)的活性和肾脏尿酸转运体(mURAT1、mGLUT9、mOAT1)的mRNA和蛋白表达水平。结果栀子苷可显著降低高尿酸血症小鼠血清尿酸水平并升高24 h尿酸排泄量,同时可抑制肝脏XOD活性,调节肾脏尿酸转运体的表达。结论栀子苷对氧嗪酸钾盐致小鼠高尿酸血症具有明显的改善作用,其作用机制可能是通过抑制XOD活性和调节尿酸转运体的表达水平实现。 Objective To investigate the effect of jasminoidin on potassium oxonate-induced hyperuricemia in mice and its mechanism. Methods Hyperuricemia was induced in mice by oral administration of potassium oxonate for 7 consecutive days. Serum uric acid levels and uric acid excretion in 24 h of mice were compared among different groups. Simultaneously, hepatic xanthine oxidase (XOD) activities, as well as mRNA and protein expressions of renal urate transpoters (mURAT1, mGLUT9, mOAT1) were analyzed. Results Jasminoidin significantly lowered the serum uric acid levels and increased the uric acid excretion at 24 h. It remarkably inhibited the hepatic XOD activities and regulated the expressions of renal urate transporters in mice. Conclusion Jasminoidin may obviously improve potassium oxonate-induced hypenaricemia in mice inhibiting hepatic XOD activities and regulating expressions of renal urate transpoters.
出处 《中南药学》 CAS 2013年第10期721-725,共5页 Central South Pharmacy
基金 国家自然科学基金青年项目(No.NSFC81202573)
关键词 栀子苷 高尿酸血症 黄嘌呤氧化酶 尿酸转运体 jasminoidin hyperuricemia xanthine oxidase urate transporters
  • 相关文献

参考文献23

  • 1Vazquez-Mellado J, Alvarez Hemandez E, Burgos-Vargas R. Pri- mary prevention in rheumatology: the importance of hyperuricemia [J]. Best Pract Res Clin Rheumatol, 2004, 18 ( 2 ) : 111-124.
  • 2Villegas R, Xiang YB, Cai Q, et al. Prevalence and determinants of hyperuricemia in middle-aged, urban Chinese men [J]. Metab SyndrRelatDisord, 2010, 8 (3): 263-270.
  • 3Puig JG, Martinez MA. Hyperuricemia, gout and the metabolic syndrome [J]. Current Opinion in Rheumatology, 2008, 20 ( 2 ) : 187-191.
  • 4Choi HK, Ford ES. Prevalence of the metabolic syndrome in in- dividuals with hyperuricemia [J]. Am J Med, 2007, 120 ( 5 ) : 442-447.
  • 5Riches PL, Wright AF, Ralston SH. Recent insights into the pathogenesis of hyperuricaemia and gout [J]. Hum Mol Genet, 2009, 18 (R2) : 177-184.
  • 6孔悦,张冰,刘小青,张浩军,萨翼,叶国华.黄嘌呤氧化酶活性在高尿酸血症动物模型中的变化[J].北京中医药大学学报,2004,27(6):38-40. 被引量:39
  • 7Hosoyamada M, Ichida K, Enomoto A, et al. Function and loca- lization of urate transporter 1 in mouse kidney [J]. J Am Soc Neph- rol, 2004, 15 (2) : 261-268.
  • 8Preitner F, Bonny O, Laverriere A, et al. Glut9 is a major regu- lator of urate homeostasis and its genetic inactivation induces hype- ruricosuria and urate nephropathy [J]. Proe Natl Acad Sei USA, 2009, 106 (36) : 15501-15506.
  • 9Nigam SK, Bush KT, Bhatnagar V. Drug and toxicant handling by the OAT organic anion transporters in the kidney and other tissu- es [J]. Nat Clin Pratt Nephrol, 2007, 3 ( 8 ) : 443-448.
  • 10Hu QH, Zhu JX, Ji J, et al. Fructus gardenia extract ameliorates oxonate-Induced hyperuricemia with renal dysfunction in mice by regulating organic ion transporters and mOIT3 [J]. Molecules, 2013, 18 (8) : 8976-8993.

二级参考文献23

共引文献153

同被引文献643

引证文献35

二级引证文献998

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部